Updated Jul 16, 2026
SPIEGELMAN DANIEL K has filed 3 SEC Form 4 filings across 3 companies in the last 90 days.
Daniel K. Spiegelman is a corporate director involved with several biopharmaceutical companies, including vTv Therapeutics Inc. and Maze Therapeutics, Inc. He has participated in multiple SEC filings related to his roles but does not appear to have significant public recognition.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-05-29 | KYTX | Kyverna Therapeutics, Inc. | A — Grant or award | 16.6K | $0.00 |
Daniel K. Spiegelman is a corporate director involved with several biopharmaceutical companies, including vTv Therapeutics Inc. and Maze Therapeutics, Inc. He has participated in multiple SEC filings related to his roles but does not appear to have significant public recognition.…
3 primary Form 4 filings in the last 90 days, covering 3 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live SPIEGELMAN DANIEL K profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.